glp-1 drugs mechanism of action and the kidney: from physiology to pharmacology and outcomes in diabetes Mechanisms of GLP-1 Receptor Agonist-Induced
Description
doi: 10.1080/20013078.2019.1617000 64 GriffithsSK
Copyright 2024 HealthDay
These agonists are developed to maximize metabolic benefits and reduce side effects (126)
Although these agents are approved for certain individuals aged 12 years and older, we will discuss evidence related to the use of injectable semaglutide and liraglutide for weight management in adults
